AzTrials
AzTrials

Inguinal Hernia BilateralNCT04679116

Laparoscopic vs Open Bilateral Inguinal Hernia Repair

A study testing Laparoscopic bilateral inguinal hernia repair and Open bilateral inguinal hernia repair in people with Inguinal Hernia Bilateral, run by General Hospital of Larissa at 1 site in Greece.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The European Hernia Society Guidelines of 2018 suggest that laparoscopic surgery should be preferred over open surgery for bilateral inguinal hernia repair even though scientific evidence are scarce. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
Inguinal Hernia Bilateral
What is being tested?
Laparoscopic bilateral inguinal hernia repair and Open bilateral inguinal hernia repair
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteGreece
Study dates
2 Jan 2021to Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • bilateral inguinal hernia

Who cannot join

  • American Society of Anaesthesiology score >3
  • complicated inguinal hernias

Trial locations and contacts

1 site in 1 country.

Georgios D Koukoulis, MD, PhD contact

00302413504366

georgios.koukoulis@gmail.com

Greece1 site, 1 recruiting
  • General Hospital Of Larissa

    Larissa, 41221

    Georgios Koukoulis, MD, georgios.koukoulis@gmail.com

    Recruiting

Other trials in Greece

About this study

The European Hernia Society Guidelines of 2018 suggest that laparoscopic surgery should be preferred over open surgery for bilateral inguinal hernia repair even though scientific evidence are scarce. We will conduct a prospective, non randomise control trial, to investigate the superiority of one technique over the other.

Being tested
Laparoscopic bilateral inguinal hernia repair, Open bilateral inguinal hernia repair
Keywords
bilateral inguinal hernia repair

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic bilateral inguinal hernia repairProcedure or surgery

    Laparoscopic bilateral inguinal hernia repair

  • Open bilateral inguinal hernia repairProcedure or surgery

    Open bilateral inguinal hernia repair

Study groups in NCT04679116
Study groupRoleWhat they receive
LaparoscopicOtherlaparoscopic inguinal hernia repair, TAPP
Receives: Procedure: Laparoscopic bilateral inguinal hernia repair
OpenOtheropen inguinal hernia repair
Receives: Procedure: Open bilateral inguinal hernia repair

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post operative Pain

    Evaluation of the post operative pain 24 hours after surgery. For the assessment of the pain will be used the Visual Analog Scale (VAS) score. (VAS Score Scale from 0-10, 0 no pain, 10 max pain)

    Measured: 24 hours post surgery

Secondary outcomes (6)
  1. days of hospitalization

    days that need to be hospitalised after surgery

    Measured: 30 days

  2. urinary retention

    inability to voluntarily void urine up to 8 hours post surgery

    Measured: 8 hours

  3. complications

    presence of surgery related complications

    Measured: 30 days

  4. recurrence

    recurrence of one or two of the hernias treated at the clinical evaluation one year after surgery

    Measured: 1 year

  5. chronic pain

    For the evaluation of the chronic pain will be used the registry for abdominal wall hernias Quality of Life questionnaire (EuraHS QoL) scale from 0 to 10. (0 = no pain 10=worst pain imaginable)

    Measured: 1 year

  6. foreign body sensation to the inguinal area

    For the evaluation of the foreign body sensation to the inguinal area will be used the Carolinas Comfort Scale (scale from 0 to 5, 0= no symptoms, 5 = disabling symptoms)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2020
  2. Study start2 Jan 2021
  3. Primary completionDec 2022 (estimated)
  4. Study completionDec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
prospective, non randomised
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04679116
Sponsor's protocol ID
1726
Status last verified
Feb 2021
First submitted
11 Dec 2020
Last updated
3 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • HerniaSurge Group. International guidelines for groin hernia management. Hernia. 2018 Feb;22(1):1-165. doi: 10.1007/s10029-017-1668-x. Epub 2018 Jan 12.

    PubMed 29330835

Questions about this trial

What is this clinical trial studying?

A study testing Laparoscopic bilateral inguinal hernia repair and Open bilateral inguinal hernia repair in people with Inguinal Hernia Bilateral, run by General Hospital of Larissa at 1 site in Greece.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Georgios D Koukoulis, MD, PhD (00302413504366, georgios.koukoulis@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post operative Pain (time frame: 24 hours post surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04679116, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in